Fotona has announced the appointment of Jeff Duchemin as group president and CEO.
Duchemin brings an extensive leadership experience in the global medical technology sector, having held senior roles in both US and international markets. Most recently, he served in executive roles in the Interventional Surgery and Integrated Diagnostic Solutions business at Becton Dickinson, along with being the former president and CEO of Harvard Biosciences. His expertise in driving revenue growth — both organically and through strategic acquisitions — will play a main role in supporting Fotona’s innovation blueprint and expanding its presence globally. Duchemin holds an MBA from Southern New Hampshire University and a BS in Accounting from the University of Massachusetts Dartmouth.
“Jeff is a visionary leader with a strong track record of driving global success in the life sciences and medical device industries,” said Jay Katzen, executive chairman, Fotona. “We are excited to have him join Fotona, which has industry leading experts and solutions, to lead Fotona through its next chapter of innovation and market leadership.”
“Innovation is at the heart of Fotona,” said Duchemin. “I’m passionate about accelerating growth by enhancing our current solutions and introducing breakthrough technologies. Fotona has a solid foundation, exceptional talent, and world-class products. It’s an honor to lead the company at such a pivotal time in its journey.”
Last year, Fotona marked 60 years of innovation in laser technology. Throughout its history, the company has remained ahead with industry advancements, including the integration of dual laser wavelengths (Er:YAG and Nd:YAG) within a single system. Most recently, Fotona launched the Dynamis Max, an aesthetic platform offering expanded versatility, improved usability, and enhanced treatment efficiency for more than 100 advanced treatment applications.
